Noktüri

Hashim H, Blanker MH, Drake MJ, Djurhuus JC, Meijlink J, Morris V, vd. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn 2019;38(2):499-508.

Ochoa DC, Hashim H. The Importance of Terminology for Quantifying Nocturia in Practice. Eur Urol Focus 2022;8(1):81-85.

Jhaveri J, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Wu EQ. The Economic Burden of Nocturia on the U.S. Health Care System and Society: A National Health and Nutrition Examination Survey Analysis. J Manag Care Spec Pharm 2019;25(12):10.18553/jmcp.2019.19191.

Vaughan CP, Fung CH, Huang AJ, Johnson TM, Markland AD. Differences in the Association of Nocturia and Functional Outcomes of Sleep by Age and Gender: a Cross-sectional, Population-Based Study. Clin Ther 2016;38(11):2386.

Przydacz M, Chlosta P. Nocturia at the Population Level in Poland: Prevalence, Bother, Quality of Life, and Treatment-Related Behavior. Healthcare 2021;9(5):555.

Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, vd. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50(6):1306-1315.

Warner WB, Hurtado EA. Nocturia. Encyclopedia of Sleep 2024:V4-469-V4-473.

Bliwise DL, Wagg A, Sand PK. Nocturia: A Highly Prevalent Disorder With Multifaceted Consequences. Urology 2019;133S:3-13.

Van Dijk L, Kooij DG, Schellevis FG. Nocturia in the Dutch adult population. BJU Int 2002;90(7):644-648.

Tikkinen KAO, Tammela TLJ, Huhtala H, Auvinen A. Is nocturia equally common among men and women? A population based study in Finland. J Urol 2006;175(2):596-600.

Coyne KS, Zhou Z, Bhattacharyya SK, Thompson CL, Dhawan R, Versi E. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 2003;92(9):948-954.

Tikkinen KAO, Johnson TM, Tammela TLJ, Sintonen H, Haukka J, Huhtala H, vd. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol 2010;57(3):488-498.

Van Kerrebroeck P, Andersson KE. Terminology, epidemiology, etiology, and pathophysiology of nocturia. Neurourol Urodyn 2014;33 Suppl 1:S2-S5.

Kowalik CG, Cohn JA, Delpe S, Reynolds WS, Kaufman MR, Milam DF, vd. Nocturia: Evaluation and Current Management Strategies. Rev Urol 2018;20(1):1.

Khan S, Wolin KY, Pakpahan R, Grubb RL, Colditz GA, Ragard L, vd. Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia. BMC Urol 2021;21(1). doi:10.1186/S12894-021-00816-5.

Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, vd. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int 2015;115(1):24-31.

Asplund R. Nocturia in relation to sleep, health, and medical treatment in the elderly. BJU Int 2005;96 Suppl 1(SUPPL. 1):15-21.

Monaghan TF, Augdelo CW, Weiss JP. Nocturia. Penn Clinical Manual of Urology, Third Edition 2024:380-399.e2.

Williams V, Qin S, Romano CDM, Lewis S, Williams N, Yarr S, vd. Psychometric evaluation of the Nocturia Sleep Quality Scale based on data from a prospective observational study. J Clin Sleep Med 2021;17(4):691.

Bliwise DL, Dijk DJ, Juul K V. Nocturia is associated with loss of deep sleep independently from sleep apnea. Neurourol Urodyn 2015;34(4):392.

Pesonen JS, Vernooij RWM, Cartwright R, Aoki Y, Agarwal A, Mangera A, vd. The Impact of Nocturia on Falls and Fractures: A Systematic Review and Meta-Analysis. J Urol 2020;203(4):674-683.

Cornu JN, Abrams P, Chapple CR, Dmochowski RR, Lemack GE, Michel MC, vd. A Contemporary Assessment of Nocturia: Definition, Epidemiology, Pathophysiology, and Management—a Systematic Review and Meta-analysis. Eur Urol 2012;62(5):877-890.

Nishiwaki T, Kawase K, Nishino Y, Matsuoka K, Ihara T, Makabe S, vd. Prediction of nocturnal polyuria in patients with nocturia based on voiding frequency. Int Urol Nephrol 2025. doi:10.1007/S11255-025-04402-8.

Monaghan TF, Epstein MR, Bliwise DL, Michelson KP, Wu ZD, Lazar JM, vd. Time of peak nocturnal diuresis rate between men with secondary nocturnal polyuria versus nocturnal polyuria syndrome. Neurourol Urodyn 2020;39(2):785-792.

Chang TL, Kuo HC. Nocturia, nocturnal polyuria, and nocturnal enuresis in adults: What we know and what we do not know. Tzu-Chi Medical Journal 2024;36(4):370.

Kamperis K, Hagstroem S, Radvanska E, Rittig S, Djurhuus JC. Excess diuresis and natriuresis during acute sleep deprivation in healthy adults. Am J Physiol Renal Physiol 2010;299(2). doi:10.1152/AJPRENAL.00126.2010.

Warner WB, Hurtado EA. Nocturia. Encyclopedia of Sleep 2024:V4-469-V4-473.

D’Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H, vd. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn 2019;38(2):433-477.

Nguyen LN, Randhawa H, Nadeau G, Cox A, Hickling D, Campeau L, vd. Canadian Urological Association best practice report: Diagnosis and management of nocturia. Canadian Urological Association Journal 2022;16(7):E336.

Burton C, Weiss JP, Parsons M, Blaivas JG, Coats AC. Reference values for the Nocturnal Bladder Capacity Index. Neurourol Urodyn 2011;30(1):52-57.

Monaghan TF, Augdelo CW, Weiss JP. Nocturia. Penn Clinical Manual of Urology, Third Edition 2024:380-399.e2.

Hashim H, Abrams P. How should patients with an overactive bladder manipulate their fluid intake? BJU Int 2008;102(1):62-66.

Cho SY, Lee SL, Kim IS, Koo DH, Kim HJ, Oh SJ. Short-term effects of systematized behavioral modification program for nocturia: a prospective study. Neurourol Urodyn 2012;31(1):64-68.

Robinson D, Hanna-Mitchell A, Rantell A, Thiagamoorthy G, Cardozo L. Are we justified in suggesting change to caffeine, alcohol, and carbonated drink intake in lower urinary tract disease? Report from the ICI-RS 2015. Neurourol Urodyn 2017;36(4):876-881.

Uyku Hijyen Kuralları - Uyku Merkezi - Uyku ve Uyku Bozuklukları. Available at: https://uykumerkezi.net/tr/urunler-altgrup/uyku-hijyen-kurallari/2/. Erişim Mart 16, 2025.

Leslie Stephen W, Sajja Hüseyin, Singh Şaşank. Nocturia. Treasure Island (FL): StatPearls Publishing; 2024.

Weiss JP, Everaert K. Management of Nocturia and Nocturnal Polyuria. Urology 2019;133:24-33.

Noh JW, Yoo KB, Kim KB, Kim JH, Kwon YD. Association between lower urinary tract symptoms and cigarette smoking or alcohol drinking. Transl Androl Urol 2020;9(2):312.

Yang X, Xie Y, Chen H, Zhang J, Qiu W, Pang J. Associations of cigarette use, e-cigarette use, and dual use, with nocturia and urge urinary incontinence in US adults. Tob Induc Dis 2025;23(March):1-10.

Wang T, Huang W, Zong H, Zhang Y. The Efficacy of Continuous Positive Airway Pressure Therapy on Nocturia in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis. Int Neurourol J 2015;19(3):178.

Vrooman OPJ, van Balken MR, van Koeveringe GA, van Kerrebroeck PVA, Driessen LEMJ, Schouten LJ, vd. The effect of continuous positive airway pressure on nocturia in patients with obstructive sleep apnea syndrome. Neurourol Urodyn 2020;39(4):1124-1128.

Andersson KE, Van Kerrebroeck P. Pharmacotherapy for Nocturia. Curr Urol Rep 2018;19(1):8.

Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology 2006;67(4):731-736.

Zinner N, Gittelman M, Harris R, Susset J, Kanellos A, Auerbach S. Trospium chloride improves overactive bladder symptoms: A multicenter phase III trial. Journal of Urology 2004;171(6 I):2311-2315.

Yokoyama O, Hiro S, Hotta S, Mogami S, Yamagami H. Efficacy of fesoterodine on nocturia and quality of sleep in Asian patients with overactive bladder. Urology 2014;83(4):750-755.

Weiss JP, Jumadilova Z, Johnson TM, Fitzgerald MP, Carlsson M, Martire DL, vd. Efficacy and Safety of Flexible Dose Fesoterodine in Men and Women with Overactive Bladder Symptoms Including Nocturnal Urinary Urgency. J Urol 2012;189(4):1396.

Nguyen LN, Randhawa H, Nadeau G, Cox A, Hickling D, Campeau L, vd. Canadian Urological Association best practice report: Diagnosis and management of nocturia. Canadian Urological Association Journal 2022;16(7):E336.

Chapple CR, Montorsi F, Tammela TLJ, Wirth M, Koldewijn E, Fernández Fernández E. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol 2011;59(3):342-352.

Johnson TM, Jones K, Williford WO, Kutner MH, Issa MM, Lepor H. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. J Urol 2003;170(1):145-148.

Michel MC, Schumacher H, Mehlburger L, de la Rosette JJMCH. Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study. Front Pharmacol 2020;11:816.

Johnson TM, Burrows PK, Kusek JW, Nyberg LM, Tenover JL, Lepor H, vd. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol 2007;178(5):2045-2051.

Takahashi R, Sumino Y, Miyazato M, Nishii H, Oshiro T, Mimata H, vd. Tadalafil Improves Nocturia and Nocturia-Related Quality of Life in Patients with Benign Prostatic Hyperplasia (KYU-PRO Study). Urol Int 2020;104(7-8):587-593.

Hirahara N, Harikai S, Fujihara A, Yamada Y, Ushijima S, Ukimura O. Efficacy of tadalafil on symptom-specific bother in men with lower urinary tract symptoms. Low Urin Tract Symptoms 2022;14(5):393-400.

Addla SK, Adeyoju AB, Neilson D, O’Reilly P. Diclofenac for treatment of nocturia caused by nocturnal polyuria: a prospective, randomised, double-blind, placebo-controlled crossover study. Eur Urol 2006;49(4):720-726.

Falahatkar S, Mokhtari G, Pourreza F, Asgari SA, Kamran AN. Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study. Urology 2008;72(4):813-816.

Gokkaya CS, Aktas BK, Ozden C, Bulut S, Karabakan M, Erkmen AE, vd. Flurbiprofen alone and in combination with alfuzosin for the management of lower urinary tract symptoms. Cent European J Urol 2015;68(1):51-56.

Simaioforidis V, Papatsoris AG, Chrisofos M, Chrisafis M, Koritsiadis S, Deliveliotis C. Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia. Int J Urol 2011;18(3):243-248.

Choi WS, Ku JH, Oh SJ, Kim SW, Paick JS. Change of nocturnal polyuria after holmium laser enucleation of the prostate in patients with benign prostatic hyperplasia. Urology 2014;84(3):650-656.

Yuce A, Benli E, Cirakoglu A, Yazici I, Nalbant I. Bipolar radiofrequency thermotherapy vs. transurethral resection of the prostate: Effect on nocturia as a result of benign prostatic obstruction. Canadian Urological Association Journal 2022;16(11):E545.

Mattiasson A, Abrams P, Van Kerrebroeck P, Walter S, Weiss J. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 2002;89(9):855-862.

Lose G, Lalos O, Freeman RM, Van Kerrebroeck P. Efficacy of desmopressin (Minirin) in the treatment of nocturia: A double-blind placebo-controlled study in women. Am J Obstet Gynecol 2003;189(4):1106-1113.

Rembratt A, Riis A, Norgaard JP. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourol Urodyn 2006;25(2):105-109.

Burke CA, Nitti VW, Stothers L. Melatonin and melatonin receptor agonists in the treatment of nocturia: A systematic review. Neurourol Urodyn 2024;43(4):826-839.

Janssen DAW, Martens FMJ, de Wall LL, van Breda HMK, Heesakkers JPFA. Clinical utility of neurostimulation devices in the treatment of overactive bladder: current perspectives. Med Devices (Auckl) 2017;10:109.